Gaxos.ai Inc. (GXAI) Dividend History

Company News

• Gaxos.ai Inc. Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

  Gaxos.ai Inc. announced the closing of a $5 million registered direct offering, issuing 1,449,277 shares of common stock at $3.45 per share. The company also issued warrants to purchase up to 1,449,277 shares at $3.32 per share. The proceeds will be used for working capital and general corporate purposes.

  GlobeNewswire Inc.
• Gaxos.ai Inc. Announces Exercise of Warrants for $3.24 Million Gross Proceeds

  Gaxos.ai Inc. (GXAI) announced the exercise of existing warrants and the issuance of new warrants, raising approximately $3.24 million. The company plans to use the proceeds for working capital and general corporate purposes.

  GlobeNewswire Inc.
• Gaxos Partners with Meshy to Deliver AI-Generated 3D Models in its Product for Game Developers and Publishers - GlobeNewswire

  Gaxos.AI has partnered with Meshy to integrate the latter's 3D generative AI features into Gaxos' product for game developers and publishers, allowing them to create detailed and immersive 3D models more easily.

  GlobeNewswire Inc.
• Gaxos Health Expands Medical Advisory Board

  Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell.

  GlobeNewswire Inc.
• Gaxos.ai Inc. Announces Closing of $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules

  Roseland, NJ, March 15, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it has closed its previously announced private placement for the purchase and sale of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a purchase price of $5.57 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants have an exercise price of $5.50 per share and are exercisable immediately upon issuance. The series A warrants expire five and one-half years from the date of issuance and short-term series B warrants expire twenty-four months from the date of issuance.

  GlobeNewswire Inc.